Revolution Medicines (RVMD) EBT (2019 - 2025)
Historic EBT for Revolution Medicines (RVMD) over the last 7 years, with Q3 2025 value amounting to -$305.2 million.
- Revolution Medicines' EBT fell 9528.43% to -$305.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$961.7 million, marking a year-over-year decrease of 6970.19%. This contributed to the annual value of -$600.8 million for FY2024, which is 3658.97% down from last year.
- According to the latest figures from Q3 2025, Revolution Medicines' EBT is -$305.2 million, which was down 9528.43% from -$247.8 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' EBT ranged from a high of -$37.2 million in Q1 2021 and a low of -$305.2 million during Q3 2025
- Moreover, its 5-year median value for EBT was -$98.3 million (2023), whereas its average is -$118.1 million.
- Per our database at Business Quant, Revolution Medicines' EBT crashed by 750.63% in 2022 and then plummeted by 18464.42% in 2023.
- Quarter analysis of 5 years shows Revolution Medicines' EBT stood at -$52.7 million in 2021, then fell by 7.51% to -$56.6 million in 2022, then tumbled by 184.64% to -$161.2 million in 2023, then decreased by 21.17% to -$195.3 million in 2024, then tumbled by 56.26% to -$305.2 million in 2025.
- Its EBT was -$305.2 million in Q3 2025, compared to -$247.8 million in Q2 2025 and -$213.4 million in Q1 2025.